At a glance
ClinicalIndex Comparison RecordN/ACompleted· 329 enrolled
Drug / intervention
QFR (observational)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diagnostic Accuracy of On-line Quantitative Flow Ratio. Functional Assessment by Virtual Online Reconstruction (The FAVOR II Europe-Japan Study)
In Brief
An observational study evaluating QFR (observational) for Coronary Artery Disease. Completed, enrolled 329 participants across 10 sites in 7 countries.
Detailed Summary
Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. QFR is assessed by calculation of the pressure in the vessel based on two angiographic projections. The purpose of the FAVOR II study is to evaluate the diagnostic accuracy of on-line QFR compared to 2D Quantitative Coronary Angiography (QCA) with FFR as gold standard.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesDenmark, France, Germany, Italy, Japan, Netherlands, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartFeb 2017
Primary CompletionOct 2017
Study CompletionJun 2018
TodayJul 2026
First PostedNov 9, 2016
Enrollment StartFeb 22, 2017
Primary CompletionOct 17, 2017
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.6 years ago
Interventions
QFR (observational)other
QFR assessment by Medis Suite, Medis medical imaging B.V., The Netherlands